Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Benzer Materyaller

• Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
  Yazar:: Filippi, M, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
  Yazar:: Filippi, M, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• In vivo transport of Gd-DTPA(2-) into human meniscus and cartilage assessed with delayed gadolinium-enhanced MRI of cartilage (dGEMRIC)
  Yazar:: Sigurdsson, Ulf, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates
  Yazar:: Nwe, K., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.
  Yazar:: Filippi, M, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)